Liminatus Pharma Ownership | Who Owns Liminatus Pharma?
Liminatus Pharma Ownership Summary
Liminatus Pharma is owned by 3.98% institutional investors, 33.75% insiders, and 62.27% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of LIMN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 2.96% of its assets in Liminatus Pharma shares.
LIMN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Liminatus Pharma | 3.98% | 33.75% | 62.27% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Geode capital management | - | - | - |
| Two sigma securities | - | - | - |
| Barclays | - | - | - |
| Jane street group | - | - | - |
| State street | - | - | - |
| Virtu financial | - | - | - |
| Ubs group | - | - | - |
| Stonex group | - | - | - |
| Farther finance advisors | - | - | - |
| Citigroup | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Geode capital management | - | - | - |
| Two sigma securities | - | - | - |
| Barclays | - | - | - |
| Jane street group | - | - | - |
| State street | - | - | - |
| Virtu financial | - | - | - |
| Ubs group | - | - | - |
| Stonex group | - | - | - |
| Farther finance advisors | - | - | - |
| Citigroup | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farther finance advisors | - | - | -14.00 |
| Blackrock funding, inc. /de | - | - | -313.00 |
| Barclays | - | - | -4.29K |
| Citigroup | - | - | -6.77K |
| Ubs group | - | - | -16.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Geode capital management | - | - | -138.42K |
| Jane street group | - | - | -71.32K |
| Vanguard capital management | - | - | -50.44K |
| Virtu financial | - | - | -27.47K |
| Stonex group | - | - | -26.06K |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -14.00 |
| Blackrock funding, inc. /de | -313.00 |
| Barclays | -4.29K |
| Citigroup | -6.77K |
| Ubs group | -16.73K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 14 | -6.67% | 945,955 | -35.89% | 3 | 10.32% | 5 | -54.55% | 6 | 100.00% |
| Mar 31, 2026 | 15 | 25.00% | 1,475,438 | 365.15% | 6 | 348.35% | 11 | 83.33% | 3 | 50.00% |
| Dec 31, 2025 | 12 | 20.00% | 317,193 | 21.10% | 1 | 141.98% | 6 | - | 2 | 100.00% |
| Sep 30, 2025 | 10 | - | 261,924 | 27.95% | - | 125.66% | 6 | -40.00% | 1 | - |
| Jun 30, 2025 | 10 | - | 204,702 | - | - | - | 10 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Nasdaq Composite Index | 39.70K | 2.96% | 39.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 50.44K | 0.19% | - |
| Fidelity Extended Market Index | 2.41K | 0.18% | - |
| Blackrock Extended Mkt Fund CF | 12.94K | 0.05% | - |
| Extended Equity Market Fund E | 12.94K | 0.03% | - |
| Extended Equity Market Fund B | 12.94K | 0.03% | - |
| BlackRock Extended Equity Market Fund K | 11.02K | 0.02% | -81.00 |
| NT Ext Equity Mkt Index Fund - Lending | 4.50K | 0.02% | - |
| NT Ext Equity Mkt Index Fund - NL | 3.70K | 0.01% | - |
| Spartan Total Market Index Pool G | 3.62K | 0.01% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
LIMN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools